2LB Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer who have previously received platinum- based chemotherapy (INTEREST)

✍ Scribed by J.Y. Douillard; E.S. Kim; V. Hirsh; T. Mok; M. Socinski; R. Gervais; L.Y. Wu; L. Li; M. Sellers; E. Lowe

• Book ID: 118624938
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 39 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70095-2